1. Efficacy of Oxycodone for Dyspnea in End-stage Heart Failure with Renal Insufficiency
- Author
-
Yasuhiko Hirota, Junji Iwasaka, Masayuki Tanaka, Kazuki Uchitani, Takeshi Senoo, Aki Ohkita, Hirofumi Maeba, and Haruna Kita
- Subjects
Cardiomyopathy, Dilated ,Male ,medicine.medical_specialty ,Case Report ,030204 cardiovascular system & hematology ,oxycodone ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Refractory ,law ,Internal medicine ,Internal Medicine ,Humans ,Medicine ,terminal-stage heart failure ,Renal Insufficiency ,030212 general & internal medicine ,Depression (differential diagnoses) ,Aged ,Heart Failure ,business.industry ,Dilated cardiomyopathy ,General Medicine ,dyspnea ,medicine.disease ,Intensive care unit ,respiratory tract diseases ,Analgesics, Opioid ,Treatment Outcome ,Opioid ,Anesthesia ,Heart failure ,Cardiology ,Morphine ,business ,Oxycodone ,medicine.drug - Abstract
A 67-year-old man with dilated cardiomyopathy and renal insufficiency was admitted to our hospital with dyspnea secondary to end-stage heart failure. We introduced oxycodone for medically refractory dyspnea instead of morphine because of the patient's renal insufficiency. After the administration of oxycodone, his dyspnea was alleviated without any adverse opioid effects, such as respiratory depression. After treating his heart failure, he was able to leave the intensive care unit. Oxycodone may therefore be a reliable agent for the treatment of dyspnea in patients with end-stage heart failure and renal insufficiency.
- Published
- 2018
- Full Text
- View/download PDF